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Available online 24 May 2016Peripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 63-year old woman
with late onset Alzheimer's disease (LOAD). The PMBCs were reprogrammed with the human OSKM transcrip-
tion factors using the Sendai-virus delivery system. The transgene-free iPSC showed pluripotency veriﬁed by im-
munocytochemistry for pluripotency markers and differentiated spontaneously towards the 3 germ layers in
vitro. Furthermore, the iPSC line showed normal karyotype. Our model might offer a good platform to further
study the pathomechanism of sporadic AD, to identify early biomarkers and also for drug testing and gene ther-
apy studies.
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Blood samples were donated by a 63-year old female patient with
clinically characterised late onset Alzheimer's disease (LOAD) by the In-
stitute of Genomic Medicine and Rare Disorders, Semmelweis Universi-
ty, Budapest (Hungary).
To generate the BIOT-0726-LOAD iPSC line (Fig. 1A) the four
“Yamanaka reprogramming factors” OCT3/4, SOX2, KLF4, and C-
MYC were delivered into PBMCs using the integration-free Sendai
virus gene-delivery method (Yang et al. 2008; Fusaki et al. 2009).
The iPSC-like colonies were picked after 20–27 days post-trans-
duction. Beginning from passage 5 of the iPSCs the absence/pres-
ence of Sendai virus vector was analysed by RT-PCR using Sendai
virus vector (SeV) - speciﬁc primers (Table 1). After 7 passages,
the elimination of the reprogramming vector was conﬁrmed in
BIOT-0726-LOAD iPSC line which was selected for further analysis
(Fig. 1B).
The karyotype of the BIOT-0726-LOAD iPSC line was determined
with Giemsa-banding, proving normal diploid 46, XX karyotype, with-
out any detectable abnormalities (Fig. 1B).
Expression of pluripotency markers was examined by immuno-
cytochemistry staining, using antibodies against human OCT3/4,
E-CADHERIN, and NANOG (Fig. 1A). The in vitro spontaneous differ-
entiation potential towards the three germ layer of the BIOT-0726-
LOAD iPSC line was demonstrated by the expression of ectodermal
(βIII-TUBULIN), mesodermal (BRACHYURY) and endodermal
(GATA4) markers (Fig. 1A) (Itskovitz-Eldor et al. 2000; Carpenter
et al. 2003).the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1.Characterisation of BIOT-0726-LOADhiPSC line A) Above:Morphology of generated hiPSCs (4×) and representative immunoﬂuorescentmicrographs of iPSCs positive for stem cells
markers OCT3/4, NANOG and E-CADHERIN (in green). Alkaline phosphatase (AP) activity was also detected in iPSCs. Below: Spontaneously formed EBs in suspension culture (Day 5) and
after attachment and further differentiation (Day 14). Immunostainings for endodermal (GATA4), mesodermal (BRACHYURY) and ectodermal (βIII-TUBULIN) germ layers, markers (in
green). Nucleus is labelledwith DAPI (in blue). B) RT-PCR veriﬁcation of the absence of Sendai-virus from the reprogrammed cells and karyogram showing normal 46 chromosomes (XX).
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Reprogramming of peripheral blood mononuclear cells (PBMC)
PBMCs were isolated within 2 h post-collection using the
Vacutainer® CPT™ Cell Preparation Tube with Sodium Heparin, (BD
Biosciences) and separated by centrifugation (1800 rcf, 30 min, room
temperature (RT). The freshly isolated PBMCs were seeded
(0.5 × 106 cells) in ExpansionMedium (EM): QBSF-60medium (Quality
Biological) supplemented with 50 μg/ml Ascorbic acid, 1% Penicillin/
Streptomycin, 50 ng/ml SCF (R&D systems), 10 ng/ml IL-3 (R&D sys-
tems), 2 U/ml EPO (R&D systems), 40 ng/ml IGF-1 (R&D systems) and
1 μMDexamethasone. Nine days later (Day 0) the cells were transduced
by Sendai-virus delivery using the CytoTune®-iPS 2.0 Sendai
Reprogramming Kit (Thermo Fisher Scientiﬁc), following the
manufacturer's instruction. Brieﬂy, the cells were transduced on 1w/
24wp in 1ml EM supplementedwith 4 μg polybrene. The calculated vol-
umes of each of the three CytoTune™ 2.0 Sendai-virus (SeV) was added
to the cells using MOI of 5-5-3 (KOS MOI = 5, hc-Myc MOI = 5, hKlf4
MOI = 3). The cell containing plate was centrifuged (900 rcf, 90 min,
RT) and incubated for 24 h. The following day the cells were collected,Table 1
Primers used in the study.
Gene symbol Fwd and Rvs primers (5′-3′) PCR product (bp)
SeV GGATCACTAGGTGATATCGAGC
ACCAGACAAGAGTTTAAGAGATATGTATC
181
RPS18S TTAAGGGTGTGGGCCGAAGA
GGGATCTTGTACTGGCGTGGA
142centrifuged (300 rcf, 5 min, RT) and seeded in fresh EM (Day 1). Two
days later (Day 3) the cells were passed onto a 6 cm dish covered
with 0.1% gelatine and 0.65 × 106 Mitomycin C treated-MEF in QBSF-
60 medium (Quality Biological) supplemented with 50 μg/ml Ascorbic
acid. Seven days post-transduction (Day 7) the medium was replaced
with HESC medium: DMEM/F12, 20% Knockout Serum Replacement,
1% MEM Non-Essential Amino Acid Solution, 0.1 mM β-
mercaptoethanol, 0.5% Pen/Strep, 10 ng/ml bFGF and supplemented
with 50 μg/ml Ascorbic acid. The colonies with an ES-like appearance
were manually isolated based on morphology between Day 21 to Day
27 post-transduction and cultured as iPSCs thereafter. Human iPSC cul-
tures were maintained on plates coated with Matrigel (BD Biosciences)
in mTESR-1 medium (Stem Cell Technologies) following the
manufacturer's instruction (Fig. 1A). All cells were cultured at 37 °C in
humidiﬁed atmosphere containing 5% CO2.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated from cultured cells with RNeasy Micro Kit
(Qiagen) and reverse transcribed corresponding to SuperScript III Re-
verse Transcriptase protocol (Thermo Fisher Scientiﬁc). The RT-PCR re-
action was performed using GoTaq Hot Start Green Master Mix
(Promega). To conﬁrm the transgene-free status of the iPSC lines, SeV
speciﬁc primers were used described in CytoTune®-iPS 2.0 Sendai
Reprogramming Kit protocol (Thermo Fisher Scientiﬁc; Table 1).
In vitro spontaneous differentiation
The iPSCs were harvested according to the mTeSR-1 kit protocol
(Stem Cell Technologies) and the cell clumps were plated on low at-
tachment dishes in mTeSR medium. Five days later the embryoid
Table 2
Antibodies used for immunocytochemistry.
Antibody Dilution Company (Cat #)
Pluripotency Mouse anti-E-CADHERIN 1:1000 Thermo Fisher Scientiﬁc
(13-1700)
Mouse anti-OCT4 1:50 Santa Cruz Biotechnologies
(sc-5279)
Goat anti-hNANOG 1:50 R&D (AF1997)
In vitro differentiation Rabbit anti-β-III-TUBULIN 1:2000 Covance (PRB-435P)
Rabbit anti-BRACHYURY T 1:50 Santa Cruz Biotechnologies
(sc-20109)
Mouse anti-GATA4 1:50 Santa Cruz Biotechnologies
(sc-25310)
Secondary antibodies Alexa Fluor 488 donkey anti-goat IgG 1:2000 Thermo Fisher Scientiﬁc.
(A-11055)
Alexa Fluor 488 donkey anti-mouse IgG 1:2000 Thermo Fisher Scientiﬁc
(A-21202)
Alexa Fluor 488 donkey anti-rabbit IgG 1:2000 Thermo Fisher Scientiﬁc
(A-21206)
Alexa Fluor 488 donkey anti-mouse IgM 1:2000 Thermo Fisher Scientiﬁc
(A-21042)
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ing cover slips (3–4 EBs/well), covered with 0.1% gelatin in differen-
tiation medium: DMEM, 20% FBS, 1%MEMNon-Essential Amino Acid
Solution, 0.1 mM β-mercaptoethanol, 1% Pen/Strep. The medium was
changed in every second day hereafter. The cells were ﬁxed on day 14
of differentiation with 4% PFA for ICC staining speciﬁc for the 3 germ
layers.Immunocytochemistry (ICC)
The expression of speciﬁc pluripotency and germ layer markers
were analysed using conventional ICC staining. Cells were ﬁxed in 4%
PFA (20 min, RT), permeabilized with 0.1% Triton X-100 (5 min, RT)
and blocked in 1% bovine serum albumin (1 h, RT). The cells were incu-
bated with primary antibodies (overnight at 4 °C) and visualized with
secondary antibodies. For nuclei counterstaining 0.2 μg/ml DAPI
(20 min, RT) was used. The antibodies and applied dilutions are listed
in Table 2. The cells were observed under ﬂuorescent microscope
equipped with 3D imaging module, (Axio Imager system with
ApoTome; Carl Zeiss) controlled by AxioVision 4.8.1 microscope soft-
ware (Carl Zeiss).Alkaline phosphatase (AP) staining
For detecting Alkaline phosphatase activity the 4% PFA ﬁxed cells
(20 min, RT) were stained AP solution (29.7 mM TRIS base; 6 mM
maleic acid, pH 8.5–9.0; with 0.08% MgCl2, 10.8 mM Naphtol-As
MX Phosphate; 23 μM Fast Red TR Salt; all from Sigma Aldrich) for
30 min (RT). Samples were observed with Axio Imager system
(Carl Zeiss).Karyotyping
Cells were treated with KaryoMAX® Colcemid™ Solution (Thermo
Fisher Scientiﬁc) and processed with standard methods. Standard
Giemsa-banded karyotypewas performed by Istenhegyi GeneDiagnostic
Center, Budapest (Hungary) and a minimum of 20 metaphases were
analysed. The chromosomeswere classiﬁed according to the Internation-
al System for Human Cytogenetic Nomenclature (ISCN).
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